Citations per year, relative to D M Goldenberg D M Goldenberg (= 1×)
peers
B. Le Mevel
Countries citing papers authored by D M Goldenberg
Since
Specialization
Citations
This map shows the geographic impact of D M Goldenberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D M Goldenberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D M Goldenberg more than expected).
This network shows the impact of papers produced by D M Goldenberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D M Goldenberg. The network helps show where D M Goldenberg may publish in the future.
Co-authorship network of co-authors of D M Goldenberg
This figure shows the co-authorship network connecting the top 25 collaborators of D M Goldenberg.
A scholar is included among the top collaborators of D M Goldenberg based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with D M Goldenberg. D M Goldenberg is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
Merenmies, Jussi, M. Tenhunen, Markku Heikinheimo, et al.. (2008). Radioimmunotherapy for recurrent childhood hepatoblastoma after liver transplantation. 7(3). 146.1 indexed citations
Behr, Thomas M., Torsten Liersch, Martin Béhé, et al.. (1999). Radioimmunotherapy of small volume disease of colorectal cancer metastatic to the liver: preclinical evaluation in comparison to standard chemotherapy and initial results of a phase I clinical study.. PubMed. 5(10 Suppl). 3232s–3242s.42 indexed citations
5.
Behr, Thomas M., Bernhard Wörmann, Martin Gramatzki, et al.. (1999). Low- versus high-dose radioimmunotherapy with humanized anti-CD22 or chimeric anti-CD20 antibodies in a broad spectrum of B cell-associated malignancies.. PubMed. 5(10 Suppl). 3304s–3314s.45 indexed citations
6.
Becker, Wolfgang, Thomas M. Behr, Wolfgang Rößler, et al.. (1995). 67Ga citrate versus 99mTc-labeled LL2-Fab' (anti-CD22) fragments in the staging of B-cell non-Hodgkin's lymphoma.. PubMed. 55(23 Suppl). 5771s–5773s.13 indexed citations
7.
Blend, Michael J., Mark Kozloff, Massimo Gasparini, et al.. (1995). Improved staging of B-cell non-Hodgkin's lymphoma patients with 99mTc-labeled LL2 monoclonal antibody fragment.. PubMed. 55(23 Suppl). 5764s–5770s.11 indexed citations
Blumenthal, Rosalyn D., Robert M. Sharkey, George Y. Wong, et al.. (1992). Targeted therapy of athymic mice bearing GW-39 human colonic cancer micrometastases with 131I-labeled monoclonal antibodies.. PubMed. 52(21). 6036–44.62 indexed citations
10.
Griffiths, Gary L., D M Goldenberg, F.F. Knapp, et al.. (1991). Direct radiolabeling of monoclonal antibodies with generator-produced rhenium-188 for radioimmunotherapy: labeling and animal biodistribution studies.. PubMed. 51(17). 4594–602.72 indexed citations
11.
Hansen, H. J., et al.. (1990). Preclinical evaluation of an "instant" 99mTc-labeling kit for antibody imaging.. PubMed. 50(3 Suppl). 794s–798s.32 indexed citations
12.
Sharkey, Robert M., Rosalyn D. Blumenthal, H. J. Hansen, & D M Goldenberg. (1990). Biological considerations for radioimmunotherapy.. PubMed. 50(3 Suppl). 964s–969s.24 indexed citations
13.
Blumenthal, Rosalyn D., R M Sharkey, David J. Snyder, H. J. Hansen, & D M Goldenberg. (1988). Reduction of radioantibody-induced myelotoxicity in hamsters by recombinant interleukin-1.. PubMed. 48(19). 5403–6.17 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.